SlideShare a Scribd company logo
Matrix metalloproteinase in neurological disorders Dhananjay Duberkar, Department of Neurology, PGIMER
WHAT ARE MATRIX METALLOPROTEINASES (MMPs)?
MMPs have following functional characteristics: Proteinases that degrade at least one component of the extracellular matrix Contain a zinc ion & are inhibited by chelating agents Secreted in latent form, requiring activation for proteolytic activity Inhibited by tissue inhibitors of metalloproteinases (TIMPs) Share common amino acid sequences
 why are we interested in MMPs?
Increase in research activity pertaining to MMPs & A disintegrin & metalloproteinases (ADAMs), in nervous system Implicated in myriad of neurological conditions, & also associated with important neurophysiological functions, including synaptic remodeling & long-term potentiation (LTP) More recently, demonstration that MMPs  regulate neural stem cell biology & remyelination suggests their importance in regeneration of nervous system MMPs & ADAMs are important in neuroinflammation, & recently they are linked to neurodegenerative disorders
ADAMs & TIMPS INTRODUCTION TO MMPs
GENERAL PROPERTIES OF MMPs There are 24 mammalian MMP members (MMP1–28), each product of different gene MMP4–6 are no longer used,MMP18 only been cloned from Xenopus, MMP22 is present in chickens & two versions of human MMP23 These can be subdivided on basis of domain structure With exception of the six membrane-type MMPs (MT-MMPs), MMP family members are generally secreted from cells
Signal peptide & propeptide region form part of cysteine switch, which folds over zinc in catalytic site & maintains latent state Cleavage site enables proconvertase furin to activate MMP by cleaving propeptide FN binding site is present in MMP2 & 9, connecting them with basal lamina. Catalytic zinc site is present in all MMPs  Haemopexin domain is joined to catalytic site by hinge region. MMP14 (an MT-MMP) has TMD
Collagenases Key feature is ability to cleave interstitial collagens I, II, and III at a specific site three-fourths from N-terminus  It can also digest  number of other ECM & non-ECM molecules Gelatinases Gelatinase A (MMP-2) & gelatinase B (MMP-9) digest denatured collagens, gelatins & no. of ECM including native type IV, V, XI collagen, laminin Stromelysins Besides digesting ECM components, MMP-3 activates a number of proMMPs, & its action on partially processed proMMP-1 is critical for generation of fully active MMP-1
Matrilysins Matrilysin 1 (MMP-7) & matrilysin 2 (MMP-26), also called endometase, are in this group Besides ECM components, MMP-7 processes cell surface molecules such as pro–-defensin, Fas-ligand, pro–tumor necrosis factor (TNF)-, & E-cadherin to generate soluble forms hence acting as ‘sheddases’ Membrane-Type MMPs (6) 4 are type I transmembrane proteins (MMP-14,15, 16,& 24),& 2 are GPI anchored proteins (MMP-17  & 25) With exception of MT4-MMP,  all capable of activating proMMP-2 & digest  number of ECM molecules, & MT1-MMP has collagenolytic activity on type I, II, & III collagens
ADAMs Transmembrane proteins that bind to integrins &  important in intracellular signaling & cell adhesion Chara. function - proteolytic processing of membrane-anchored precursors & subsequent release of mature proteins .This process is referred to as ‘protein ECTODOMAIN SHEDDING’ Proteins modulated include cell-surface receptor Notch & its ligand Delta, important in CNS development, amyloid precursor protein  implicated in AD(ADAM-10 an α- secretase) ,TNF-α (ADAM-17 known as TACE- TNF-α converting enzyme), & ligands of EGF receptor ADAMs are implicated in cellular proliferation, migration,    differentiation,  & survival, in axonal growth & myelination
TIMPs TIMPs are small proteins & these enzymes are codified by highly conserved genes and have overlapping functions Four TIMPs have been identified TIMPs are inhibitory against most MMPs with some predilections: TIMP1 inhibits MMP9, TIMP2 inhibits MMP2 &, paradoxically, contributes to activation of pro-MMP2 TIMP3  has role in cellular growth, cellular death, & tissue repair
ACTIONS OF TIMP – 3
Activation of ProMMPs MMPs can be activated by proteinases or in vitro by chemical agents, such as thiol-modifying agents Activation of proMMPs by plasmin is relevant in vivo Activated MMPs can participate in processing other MMPs Fine regulatory mechanisms to control destructive enzymes, TIMPs may interfere with activation by interacting with  intermediate MMP before it is fully activated
Role of MMPs in CNS
MMPs regulate CNS development –  MMP’s are expressed during nervous system ontogeny & CNS abnormalities occur when their activity is perturbed or impaired  In particular role in neurogenesis ,angiogenesis, development of oligodendrocytes & myelin MMPs have beneficial role in healthy CNS  -  Within adult CNS MMPs function in remodeling ECM. ECM will in     turn regulate cell migration & survival  Neurons remodel their synaptic connections in response to various stimuli. Synaptic environment including ECM , play imp role in neuronal plasticity & learning & memory
  3. MMPs in repair of adult CNS –  It is important that following initial & likely detrimental up regulation of several MMPs after injury, delayed, subtle & restricted expression of specific MMPs have beneficial role MMP-9 expressed 7 days after demyelinating insult  to the spinal cord of mice promotes maturation of oligodendrocytes & their formation of myelin Delayed expression of MMP-2 after traumatic spinal cord is necessary for ECM remodeling & functional recovery.
MMPs IN the cns: where the good guys go bad?
Neuroinflammation CNS injury initiates cascade of events defined as neuroinflammation Cytokine & chemokine response associated with production of free radicals & proteases TNFα, interleukin 1β, & chemokines, are implicated and tissue responses differ with specific Injury Factors that affect outcome of  inflammatory process include presence of hypoxia–ischemia, duration of injury, presence of infection & types of cells involved
MMPs in hypoxia–ischemia Basal lamina around cerebral blood vessels contains ECM proteins, including laminin, fibronectin, heparan sulphate, &  type IV collagen Proteolysis of BBB by MMPs results in loss of basal lamina proteins, which increases the risk of hemorrhage MMP2, MMP3, and MMP9 increase permeability of BBB. Inhibitors of MMPs can reduce damage to BBB In ischemia with reperfusion, MMPs are induced & disrupt BBB; for instance, in Mmp9 knockout model, focal ischemic lesions decreased the damage to the blood–brain barrier & infarct size
MMP In autoimmune disorder & infection Immunological or infectious pathogen, main injury site  is blood vessels alone. Whenever BBB is affected, MMP9 is key factor in injury process Exacerbation of acute MS increases MMP9 concentrations in CSF & treatment with steroid reduces MMP9 concentrations Treatment with MMP inhibitor GM-6001 suppresses development of clinical experimental allergic encephalomyelitis in mice In rats with experimental allergic neuritis, a broad spectrum MMP inhibitor, BB-1101, which also inhibits TACE, reduces damage to nerves
Metalloproteinases regulate myelinogenesis.  A. MMP9/12 in maturation of oligodendrocytes precursor cells to oligodendrocytes & extension of their processes MMP9 and 12 are known to influence myelin formation during development, this is achieved through effect of these MMPs on bioavailability ofIGF1. IGFBP6,. B. Demyelination in adult mouse spinal cord, MMP9 regulates remyelination. mechanism is clearance of NG2 proteoglycans, which constitutes an inhibitory barrier for maturation of oligodendrocytes & their subsequent reformation of myelin.
Matrix metalloproteinase in neuroinflammation & MS: Neuroscientist 2002; 8; 586
MMPs in Neurodegeneration
MMP in vascular cognitive impairment MMPs are induced by hypoxic hypoperfusion in white matter During hypoxia, HIF1α increases, leading to expression of many genes implicated in injury  & repair Furin contributes to activation of MMPs implicated in injury  HIF1α stimulates expression of substances that mediate repair, including  VEGF & TGFβ In rat model of VCI , hypoxic hypoperfusion induces MMPs & thus increases permeability of  BBB in white matter
Possible mechanism for white matter injury in vascular cognitive impairment HIF1α concentration, turns on cassettes of genes associated with injury such as FURIN, & increases expression of VEGF and TGFβ, which are important in repair. Furin leads to activation of MMP2 through activation of MT-MMP. MMP2 can disrupt  tight junction proteins & open the BBB, leading to edema. Edema might also cause demyelination. Additionally, MMP2 might attack myelin and can activate endothelin 1, which causes vasoconstriction through calcium metabolism in small muscle. Vasoconstriction aggravates hypoxic state. Conversely, on the repair side, VEGF and TGFβ activate angiopoietin 2, which acts through the secretion of MMPs to initiate angiogenesis and neurogenesis.
(E) Immunostaining with antibodies to MMP3 detects an immunoreactive astrocytes (arrow). (F) Immunostaining with antibodies to MMP3 detects an MMP3-positive macrophage around a fibrotic blood vessel in demyelinated area (arrow).
MMPs & ADAMs in AD MMPs participate in formation & clearance of  amyloid-β peptides (Aβ)  MMPs are induced endogenously by amyloid molecules in blood vessels, astrocytes, & microglia Astrocytes exposed to Aβ1-40 secrete MMP2,3 & 9 When Aβ is deposited in tissues around plaques, there is activation of microglia & astrocytosis, this inflammatory response might contribute to neuronal Death Increase in expression of MMPs in brain tissue & blood of patients with AD is probably part of inflammatory response
ADAMs are part of α- secretase α-secretase cleaves APP molecule, soluble fragment of APP is produced (APPsα), which can be further metabolized by proteases & cleared from brain across  BBB. However, if β-secretase initiates cleavage of APP to form interim product that γ-secretase cleaves, then the Aβ molecule is formed. Most common form of Aβ is Aβ1-40, which is degraded by MMPs  cleared through BBB : a smaller amount of Aβ1-42 is formed, but this can clump into fibrils that accumulate in amyloid plaques. MMP2 and MMP9 degrade Aβ & aid in its clearance from brain across BBB. Furthermore, microglia are activated by Aβ, adding to the amount of MMP9 available. Aβ=am
MMPs in Parkinson’s disease In vitro, apoptotic dopaminergic neurons release MMP3, which activates microglia , suggesting that, MMP3 is signalling molecule in addition. TNFα released from microglia leads to neuronal death;  Primary mouse mesencephalic cells in culture die when treated with BH4 (tetrahydrobiopterin), selective dopaminergic neuronal toxin; treatment with MMP3 inhibitor NNGH (N-isobutyl-N-[4-methoxyphenylsulfonyl]-glycylhydroxamic acid) prolongs cell survival by decreasing TNFα release from activated microglia.
Determinants of beneficial or detrimental roles
At least 3 factors contribute Stage of CNS injury –  it is likely that in early phase after insult, when many metalloproteinases are induced or released into milieu that normally has low levels of protease MMPs are detrimental Indeed, in rodents,  early & short-term treatment (for 3 days) of spinal cord injury or intracerebral hemorrhage with metalloproteinase inhibitors attenuates extent of neurotoxicity & subsequent loss of function More latterly after injury, when metalloproteinases are expressed discreetly and locally
Type of injury inflicted Type of injury  affects profile of inflammatory cells at  injury site & available MMP substrates expressed in that microenvironment chronic diseases such as MS & EAE entail significant representation by T lymphocytes, which promote inflammation & neurotoxicity, whereas in acute spinal cord injury, injury site is infiltrated with neutrophils & macrophages rather than T cells In different cellular contexts, & with differences in gene expression in these cell types, substrates for,& functions of, MMP differ
3.  Pathophysiology of disorder involved In EAE, recovery from disease depends on switch of CD4+ T lymphocytes from  proinflammatory Th1 subset to Th2 environment in order for inflammation to subside MMP12 may be required for this switch,& its absence results in animals with more inflamed CNS & greater EAE severity  By contrast, in cord injury, which represents insult less dependent on T cells, MMP12 may not be required to alter this ratio Rather, MMP12 expression increases activation of microglia/ macrophages, which exacerbate damage to injured cord
Targeting MMP in Neurological conditions
MMP inhibitors Early recognition that excessive MMP expression contributes to diseases such as cancer led to active development of inhibitors One of first hydroxamates developed was batimastat (BB94). Marimastat second generation hydroxamate with increased bioavailability after oral intake,& has been tested in gliomas Tetracycline antibiotics inhibits MMP enzymatic activity  has led to use of these & chemically modified tetracyclines without anti-microbial activity (CMTs) as MMP inhibitors Only compound approved for use based on its ability to inhibit MMPs is low-dose doxycycline formulation, Periostat
MMP in demyelinating & inflammatory disorders
One of most potent tetracyclines to inhibit gelatinases, is minocycline. minocycline in EAE  reduces disease activity Minocycline was found to reduce relapse rate & gad enhancing MRI lesions in pilot trial in RRMS CMT as MMP inhibitors acts by binding Zn2+ &Ca2+, latter being required to maintain proper enzyme conformation CMTs  also down regulate expression of MMPs, & to decrease  oxidative activation of pro-MMPs into active enzymes Statins, are also described to reduce  production of MMPs by cells or to inhibit MMP activity
MMP INHIBITOR IN STROKE
Antibodies to MMPs & broad-spectrum MMP inhibitors, BB-94, 1101, & GM-6001, reduce BBB damage, infarct size, & cell death Protect brain from hemorrhagic complications of alteplase by reducing permeability of BBB & preventing alteplase from entering brain & activating MMPs MMP inhibitors in stroke needs to be given early in first few days after injury to prevent blocking recovery phase MRI has shown in rats that, although BB-1101 blocked early opening of BBB at 3hr after 90-min MCA occlusion with reperfusion, inhibitor had no effect on lesion size at 48 h, & recovery over 3 weeks was slowed
MMP INHIBITORS IN OTHER DISEASES
MMP inhibitors  were beneficial in animal studies of MS,GBS , meningitis & vascular dementia MMPs in bacterial meningitis  contribute to  damage seen in children with meningitis despite use of appropriate antibiotics Water-soluble inhibitor of MMPs & TACE, TNF-484, is effective in animals Doxycycline blocks secondary damage in experimental bacterial meningitis in rodents Doxycycline has been used in treatment of MMP-mediated vascular diseases & reduced vascular damage in animal model
Even more speculative is possible use of MMP inhibitors in treatment of Alzheimer’s disease Role of MMPs & ADAMs in AD is complex because of their dual function  Theoretically, treatment with MMP inhibitors could impede amyloid clearance because MMP9 seems to facilitate  removal of the amyloid peptides Use of MMP inhibitors in PD might show great promise as death of dopaminergic neurons seems to be associated with release of MMPs by the activated cells around them
WHY WE ARE NOT USING MMPs?
Major obstacle is low specificity & poor solubility particularly those with hydroxymate base Other obstacle is poor understanding of time to initiate & time to stop treatment Need to assess beneficial & deleterious effects in detail Selective inhibition VS broad spectrum inhibition Side effects
CONCLUSIONS Metalloproteinases have both beneficial and detrimental functions in the CNS  Issue of MMPs as causative factors in disease is active area of investigation, but their possible role as facilitators of CNS recovery needs greater consideration. Research needed to understand diverse roles of proteases to design specific drugs & devise therapeutic strategies The potential use of MMP inhibitors to treat CNS diseases is an exciting prospect, but it is important to balance risk with the benefits of this treatment
Matrixmetalloproteinase

More Related Content

What's hot

Fibroblasts in Health and Disease
Fibroblasts in Health and DiseaseFibroblasts in Health and Disease
Fibroblasts in Health and Disease
anusha23amit
 
Tol like receptors
Tol like receptorsTol like receptors
Tol like receptors
9925752690
 
complement and complement deficiency
complement and complement deficiencycomplement and complement deficiency
Mast cells in health and disease
Mast cells in health and disease  Mast cells in health and disease
Mast cells in health and disease
Pannaga Kumar
 
Immune response against tumors
Immune response against tumors Immune response against tumors
Immune response against tumors
qussai abbas
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
Ashwini Gowda
 
Dendritic cells
Dendritic cellsDendritic cells
Dendritic cells
Jai Kumar
 
Metastatic cascade and Epithelial Mesenchymal Transition
Metastatic cascade and Epithelial Mesenchymal TransitionMetastatic cascade and Epithelial Mesenchymal Transition
Metastatic cascade and Epithelial Mesenchymal Transition
Shruti Dogra
 
Biology of mast cells
Biology of mast cellsBiology of mast cells
Cytokines
Cytokines Cytokines
Cytokines
Navneet Randhawa
 
PMN
PMNPMN
Autoimmunity and Tolerance
Autoimmunity and ToleranceAutoimmunity and Tolerance
Autoimmunity and Tolerance
Atifa Ambreen
 
Direct Immunofluorescence in Dermatology
Direct Immunofluorescence in DermatologyDirect Immunofluorescence in Dermatology
Direct Immunofluorescence in Dermatology
Jerriton Brewin
 
Mast cells in health and disease final dr karishma
Mast cells in health and disease final   dr karishmaMast cells in health and disease final   dr karishma
Mast cells in health and disease final dr karishma
Karishma Korgaonker
 
Desmosomes
DesmosomesDesmosomes
Desmosomes
Jai Kumar
 
Toll like receptors
Toll like receptors   Toll like receptors
Toll like receptors
Dr. Tushar Patil
 
B- lymphocytes
B- lymphocytesB- lymphocytes
B- lymphocytes
yashi jain
 
thymic selection of tcells
thymic selection of tcellsthymic selection of tcells
thymic selection of tcells
naren
 
7.mmp
7.mmp7.mmp
Tolerance and autoimmunity
Tolerance and autoimmunityTolerance and autoimmunity
Tolerance and autoimmunity
Omair Riaz
 

What's hot (20)

Fibroblasts in Health and Disease
Fibroblasts in Health and DiseaseFibroblasts in Health and Disease
Fibroblasts in Health and Disease
 
Tol like receptors
Tol like receptorsTol like receptors
Tol like receptors
 
complement and complement deficiency
complement and complement deficiencycomplement and complement deficiency
complement and complement deficiency
 
Mast cells in health and disease
Mast cells in health and disease  Mast cells in health and disease
Mast cells in health and disease
 
Immune response against tumors
Immune response against tumors Immune response against tumors
Immune response against tumors
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
 
Dendritic cells
Dendritic cellsDendritic cells
Dendritic cells
 
Metastatic cascade and Epithelial Mesenchymal Transition
Metastatic cascade and Epithelial Mesenchymal TransitionMetastatic cascade and Epithelial Mesenchymal Transition
Metastatic cascade and Epithelial Mesenchymal Transition
 
Biology of mast cells
Biology of mast cellsBiology of mast cells
Biology of mast cells
 
Cytokines
Cytokines Cytokines
Cytokines
 
PMN
PMNPMN
PMN
 
Autoimmunity and Tolerance
Autoimmunity and ToleranceAutoimmunity and Tolerance
Autoimmunity and Tolerance
 
Direct Immunofluorescence in Dermatology
Direct Immunofluorescence in DermatologyDirect Immunofluorescence in Dermatology
Direct Immunofluorescence in Dermatology
 
Mast cells in health and disease final dr karishma
Mast cells in health and disease final   dr karishmaMast cells in health and disease final   dr karishma
Mast cells in health and disease final dr karishma
 
Desmosomes
DesmosomesDesmosomes
Desmosomes
 
Toll like receptors
Toll like receptors   Toll like receptors
Toll like receptors
 
B- lymphocytes
B- lymphocytesB- lymphocytes
B- lymphocytes
 
thymic selection of tcells
thymic selection of tcellsthymic selection of tcells
thymic selection of tcells
 
7.mmp
7.mmp7.mmp
7.mmp
 
Tolerance and autoimmunity
Tolerance and autoimmunityTolerance and autoimmunity
Tolerance and autoimmunity
 

Viewers also liked

The role of matrix metalloproteinase 2 (mmp 2
The role of matrix metalloproteinase 2 (mmp 2The role of matrix metalloproteinase 2 (mmp 2
The role of matrix metalloproteinase 2 (mmp 2
Feng-wei Yeh
 
The role of matrix metalloproteinase 2
The role of matrix metalloproteinase 2 The role of matrix metalloproteinase 2
The role of matrix metalloproteinase 2
Feng-wei Yeh
 
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Ahmad Usama
 
Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms final
mosaiques
 
Ardi - Tsri 2008
Ardi - Tsri 2008Ardi - Tsri 2008
Ardi - Tsri 2008
vcardi
 
BY 495 Seminar Presentation-Ashley Scheines
BY 495 Seminar Presentation-Ashley ScheinesBY 495 Seminar Presentation-Ashley Scheines
BY 495 Seminar Presentation-Ashley Scheines
Ashley Scheines
 
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direc...
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells  by direc...Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells  by direc...
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direc...
Ahmad Usama
 
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
Indian dental academy
 
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALSRECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
Ajjanagi Bhimappa
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhood
Sonic V S
 
5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing
ensteve
 
An Overview of Targeted Therapy Drugs
An Overview of Targeted Therapy DrugsAn Overview of Targeted Therapy Drugs
An Overview of Targeted Therapy Drugs
Natasha Tiffany
 
Recent advances in gene therapy
Recent advances in gene therapyRecent advances in gene therapy
Recent advances in gene therapy
purvi gosrani
 
Host modulation
Host modulationHost modulation
Host modulation
Mehul Shinde
 
Carcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspectCarcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspect
Daifallah Almansouri
 
Apu domas & carcinoid syndrome
Apu domas & carcinoid syndromeApu domas & carcinoid syndrome
Apu domas & carcinoid syndrome
Dhritiman Chakrabarti
 
Marine Pharmaceuticals
Marine PharmaceuticalsMarine Pharmaceuticals
Marine Pharmaceuticals
redcoralh2o
 
Introduction to Targeted Therapies in Oncology
Introduction to Targeted Therapies in OncologyIntroduction to Targeted Therapies in Oncology
Introduction to Targeted Therapies in Oncology
Mohamed Abdulla
 
Targeted Therapy in Cancer
Targeted Therapy in Cancer Targeted Therapy in Cancer
Targeted Therapy in Cancer
Rafael Trujillo Vílchez
 
Host modulation (2)
Host modulation (2)Host modulation (2)
Host modulation (2)
doctornirav
 

Viewers also liked (20)

The role of matrix metalloproteinase 2 (mmp 2
The role of matrix metalloproteinase 2 (mmp 2The role of matrix metalloproteinase 2 (mmp 2
The role of matrix metalloproteinase 2 (mmp 2
 
The role of matrix metalloproteinase 2
The role of matrix metalloproteinase 2 The role of matrix metalloproteinase 2
The role of matrix metalloproteinase 2
 
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
Matrix metalloproteinase 2 (MMP-2) attenuates brain tumour growth (Feb.01,2013)
 
Molecular mechanisms final
Molecular mechanisms finalMolecular mechanisms final
Molecular mechanisms final
 
Ardi - Tsri 2008
Ardi - Tsri 2008Ardi - Tsri 2008
Ardi - Tsri 2008
 
BY 495 Seminar Presentation-Ashley Scheines
BY 495 Seminar Presentation-Ashley ScheinesBY 495 Seminar Presentation-Ashley Scheines
BY 495 Seminar Presentation-Ashley Scheines
 
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direc...
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells  by direc...Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells  by direc...
Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direc...
 
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
Pediatric soft tissue lesions/certified fixed orthodontic courses by Indian d...
 
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALSRECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
RECENT ADVANCES IN TREATMENT OF NEOPLASMS IN ANIMALS
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhood
 
5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing5. Carcinoid Tumour Biochemical And Radiological Testing
5. Carcinoid Tumour Biochemical And Radiological Testing
 
An Overview of Targeted Therapy Drugs
An Overview of Targeted Therapy DrugsAn Overview of Targeted Therapy Drugs
An Overview of Targeted Therapy Drugs
 
Recent advances in gene therapy
Recent advances in gene therapyRecent advances in gene therapy
Recent advances in gene therapy
 
Host modulation
Host modulationHost modulation
Host modulation
 
Carcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspectCarcinoid tumours of small intestine; surgical aspect
Carcinoid tumours of small intestine; surgical aspect
 
Apu domas & carcinoid syndrome
Apu domas & carcinoid syndromeApu domas & carcinoid syndrome
Apu domas & carcinoid syndrome
 
Marine Pharmaceuticals
Marine PharmaceuticalsMarine Pharmaceuticals
Marine Pharmaceuticals
 
Introduction to Targeted Therapies in Oncology
Introduction to Targeted Therapies in OncologyIntroduction to Targeted Therapies in Oncology
Introduction to Targeted Therapies in Oncology
 
Targeted Therapy in Cancer
Targeted Therapy in Cancer Targeted Therapy in Cancer
Targeted Therapy in Cancer
 
Host modulation (2)
Host modulation (2)Host modulation (2)
Host modulation (2)
 

Similar to Matrixmetalloproteinase

how to run gel electrophoresis and set up
how to run gel electrophoresis and set uphow to run gel electrophoresis and set up
how to run gel electrophoresis and set up
RahulRoshan37
 
METALOPROTEINASAS.pdf
METALOPROTEINASAS.pdfMETALOPROTEINASAS.pdf
METALOPROTEINASAS.pdf
CarlosChoqueapazaCal
 
In press
In pressIn press
In press
Mustafa Siddiq
 
Regulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOR
eadvisor
 
Abstract(English)
Abstract(English)Abstract(English)
Mmp 2
Mmp 2Mmp 2
Discuss the concept and rationale of host modulation
Discuss the concept and rationale of host modulationDiscuss the concept and rationale of host modulation
Discuss the concept and rationale of host modulation
OdeyemiKolade
 
Seminar 1104
Seminar 1104Seminar 1104
Seminar 1104
宜臻 吳
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
171 mm ps the dirty dozen
SHAPE Society
 
Vp watch editorial - v2 n4- 2002
Vp watch   editorial - v2 n4- 2002Vp watch   editorial - v2 n4- 2002
Vp watch editorial - v2 n4- 2002
Society for Heart Attack Prevention and Eradication
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
gonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's diseasegonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's disease
SurbhiPanwar5
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
Kaushik Mukhopadhyay
 
Polymophism in the promoter
Polymophism in the promoterPolymophism in the promoter
research paper mesoderm
research paper mesodermresearch paper mesoderm
research paper mesoderm
Michael Meade
 
Canine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
Canine oncoprotein targets for Melanoma, Breast Cancer, OsteosarcomaCanine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
Canine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
Snehal Salunkhe
 
Dna methylation
Dna methylationDna methylation
Dna methylation
Sushma Marla
 
Host Response
Host ResponseHost Response
Immunosuppressive Drugs
Immunosuppressive DrugsImmunosuppressive Drugs
Melatonin
MelatoninMelatonin
Melatonin
arez esmail
 

Similar to Matrixmetalloproteinase (20)

how to run gel electrophoresis and set up
how to run gel electrophoresis and set uphow to run gel electrophoresis and set up
how to run gel electrophoresis and set up
 
METALOPROTEINASAS.pdf
METALOPROTEINASAS.pdfMETALOPROTEINASAS.pdf
METALOPROTEINASAS.pdf
 
In press
In pressIn press
In press
 
Regulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTORRegulation of Glycolysis downstream of mTOR
Regulation of Glycolysis downstream of mTOR
 
Abstract(English)
Abstract(English)Abstract(English)
Abstract(English)
 
Mmp 2
Mmp 2Mmp 2
Mmp 2
 
Discuss the concept and rationale of host modulation
Discuss the concept and rationale of host modulationDiscuss the concept and rationale of host modulation
Discuss the concept and rationale of host modulation
 
Seminar 1104
Seminar 1104Seminar 1104
Seminar 1104
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
171 mm ps the dirty dozen
 
Vp watch editorial - v2 n4- 2002
Vp watch   editorial - v2 n4- 2002Vp watch   editorial - v2 n4- 2002
Vp watch editorial - v2 n4- 2002
 
171 mm ps the dirty dozen
171 mm ps the dirty dozen171 mm ps the dirty dozen
171 mm ps the dirty dozen
 
gonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's diseasegonadocorticoids: a potential treatment for parkinson's disease
gonadocorticoids: a potential treatment for parkinson's disease
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Polymophism in the promoter
Polymophism in the promoterPolymophism in the promoter
Polymophism in the promoter
 
research paper mesoderm
research paper mesodermresearch paper mesoderm
research paper mesoderm
 
Canine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
Canine oncoprotein targets for Melanoma, Breast Cancer, OsteosarcomaCanine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
Canine oncoprotein targets for Melanoma, Breast Cancer, Osteosarcoma
 
Dna methylation
Dna methylationDna methylation
Dna methylation
 
Host Response
Host ResponseHost Response
Host Response
 
Immunosuppressive Drugs
Immunosuppressive DrugsImmunosuppressive Drugs
Immunosuppressive Drugs
 
Melatonin
MelatoninMelatonin
Melatonin
 

Recently uploaded

Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
Denish Jangid
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
paigestewart1632
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
Colégio Santa Teresinha
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
Jean Carlos Nunes Paixão
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
Wahiba Chair Training & Consulting
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
Dr. Mulla Adam Ali
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
mulvey2
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 

Recently uploaded (20)

Chapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptxChapter wise All Notes of First year Basic Civil Engineering.pptx
Chapter wise All Notes of First year Basic Civil Engineering.pptx
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
Cognitive Development Adolescence Psychology
Cognitive Development Adolescence PsychologyCognitive Development Adolescence Psychology
Cognitive Development Adolescence Psychology
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
MARY JANE WILSON, A “BOA MÃE” .
MARY JANE WILSON, A “BOA MÃE”           .MARY JANE WILSON, A “BOA MÃE”           .
MARY JANE WILSON, A “BOA MÃE” .
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 
A Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdfA Independência da América Espanhola LAPBOOK.pdf
A Independência da América Espanhola LAPBOOK.pdf
 
How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience How to Create a More Engaging and Human Online Learning Experience
How to Create a More Engaging and Human Online Learning Experience
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
 
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptxC1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
C1 Rubenstein AP HuG xxxxxxxxxxxxxx.pptx
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 

Matrixmetalloproteinase

  • 1. Matrix metalloproteinase in neurological disorders Dhananjay Duberkar, Department of Neurology, PGIMER
  • 2. WHAT ARE MATRIX METALLOPROTEINASES (MMPs)?
  • 3. MMPs have following functional characteristics: Proteinases that degrade at least one component of the extracellular matrix Contain a zinc ion & are inhibited by chelating agents Secreted in latent form, requiring activation for proteolytic activity Inhibited by tissue inhibitors of metalloproteinases (TIMPs) Share common amino acid sequences
  • 4. why are we interested in MMPs?
  • 5. Increase in research activity pertaining to MMPs & A disintegrin & metalloproteinases (ADAMs), in nervous system Implicated in myriad of neurological conditions, & also associated with important neurophysiological functions, including synaptic remodeling & long-term potentiation (LTP) More recently, demonstration that MMPs regulate neural stem cell biology & remyelination suggests their importance in regeneration of nervous system MMPs & ADAMs are important in neuroinflammation, & recently they are linked to neurodegenerative disorders
  • 6. ADAMs & TIMPS INTRODUCTION TO MMPs
  • 7.
  • 8. GENERAL PROPERTIES OF MMPs There are 24 mammalian MMP members (MMP1–28), each product of different gene MMP4–6 are no longer used,MMP18 only been cloned from Xenopus, MMP22 is present in chickens & two versions of human MMP23 These can be subdivided on basis of domain structure With exception of the six membrane-type MMPs (MT-MMPs), MMP family members are generally secreted from cells
  • 9.
  • 10. Signal peptide & propeptide region form part of cysteine switch, which folds over zinc in catalytic site & maintains latent state Cleavage site enables proconvertase furin to activate MMP by cleaving propeptide FN binding site is present in MMP2 & 9, connecting them with basal lamina. Catalytic zinc site is present in all MMPs Haemopexin domain is joined to catalytic site by hinge region. MMP14 (an MT-MMP) has TMD
  • 11. Collagenases Key feature is ability to cleave interstitial collagens I, II, and III at a specific site three-fourths from N-terminus It can also digest number of other ECM & non-ECM molecules Gelatinases Gelatinase A (MMP-2) & gelatinase B (MMP-9) digest denatured collagens, gelatins & no. of ECM including native type IV, V, XI collagen, laminin Stromelysins Besides digesting ECM components, MMP-3 activates a number of proMMPs, & its action on partially processed proMMP-1 is critical for generation of fully active MMP-1
  • 12. Matrilysins Matrilysin 1 (MMP-7) & matrilysin 2 (MMP-26), also called endometase, are in this group Besides ECM components, MMP-7 processes cell surface molecules such as pro–-defensin, Fas-ligand, pro–tumor necrosis factor (TNF)-, & E-cadherin to generate soluble forms hence acting as ‘sheddases’ Membrane-Type MMPs (6) 4 are type I transmembrane proteins (MMP-14,15, 16,& 24),& 2 are GPI anchored proteins (MMP-17 & 25) With exception of MT4-MMP, all capable of activating proMMP-2 & digest number of ECM molecules, & MT1-MMP has collagenolytic activity on type I, II, & III collagens
  • 13. ADAMs Transmembrane proteins that bind to integrins & important in intracellular signaling & cell adhesion Chara. function - proteolytic processing of membrane-anchored precursors & subsequent release of mature proteins .This process is referred to as ‘protein ECTODOMAIN SHEDDING’ Proteins modulated include cell-surface receptor Notch & its ligand Delta, important in CNS development, amyloid precursor protein implicated in AD(ADAM-10 an α- secretase) ,TNF-α (ADAM-17 known as TACE- TNF-α converting enzyme), & ligands of EGF receptor ADAMs are implicated in cellular proliferation, migration, differentiation, & survival, in axonal growth & myelination
  • 14.
  • 15. TIMPs TIMPs are small proteins & these enzymes are codified by highly conserved genes and have overlapping functions Four TIMPs have been identified TIMPs are inhibitory against most MMPs with some predilections: TIMP1 inhibits MMP9, TIMP2 inhibits MMP2 &, paradoxically, contributes to activation of pro-MMP2 TIMP3 has role in cellular growth, cellular death, & tissue repair
  • 16.
  • 18.
  • 19. Activation of ProMMPs MMPs can be activated by proteinases or in vitro by chemical agents, such as thiol-modifying agents Activation of proMMPs by plasmin is relevant in vivo Activated MMPs can participate in processing other MMPs Fine regulatory mechanisms to control destructive enzymes, TIMPs may interfere with activation by interacting with intermediate MMP before it is fully activated
  • 20.
  • 21.
  • 22. Role of MMPs in CNS
  • 23.
  • 24. MMPs regulate CNS development – MMP’s are expressed during nervous system ontogeny & CNS abnormalities occur when their activity is perturbed or impaired In particular role in neurogenesis ,angiogenesis, development of oligodendrocytes & myelin MMPs have beneficial role in healthy CNS - Within adult CNS MMPs function in remodeling ECM. ECM will in turn regulate cell migration & survival Neurons remodel their synaptic connections in response to various stimuli. Synaptic environment including ECM , play imp role in neuronal plasticity & learning & memory
  • 25.
  • 26. 3. MMPs in repair of adult CNS – It is important that following initial & likely detrimental up regulation of several MMPs after injury, delayed, subtle & restricted expression of specific MMPs have beneficial role MMP-9 expressed 7 days after demyelinating insult to the spinal cord of mice promotes maturation of oligodendrocytes & their formation of myelin Delayed expression of MMP-2 after traumatic spinal cord is necessary for ECM remodeling & functional recovery.
  • 27.
  • 28. MMPs IN the cns: where the good guys go bad?
  • 29. Neuroinflammation CNS injury initiates cascade of events defined as neuroinflammation Cytokine & chemokine response associated with production of free radicals & proteases TNFα, interleukin 1β, & chemokines, are implicated and tissue responses differ with specific Injury Factors that affect outcome of inflammatory process include presence of hypoxia–ischemia, duration of injury, presence of infection & types of cells involved
  • 30.
  • 31. MMPs in hypoxia–ischemia Basal lamina around cerebral blood vessels contains ECM proteins, including laminin, fibronectin, heparan sulphate, & type IV collagen Proteolysis of BBB by MMPs results in loss of basal lamina proteins, which increases the risk of hemorrhage MMP2, MMP3, and MMP9 increase permeability of BBB. Inhibitors of MMPs can reduce damage to BBB In ischemia with reperfusion, MMPs are induced & disrupt BBB; for instance, in Mmp9 knockout model, focal ischemic lesions decreased the damage to the blood–brain barrier & infarct size
  • 32.
  • 33. MMP In autoimmune disorder & infection Immunological or infectious pathogen, main injury site is blood vessels alone. Whenever BBB is affected, MMP9 is key factor in injury process Exacerbation of acute MS increases MMP9 concentrations in CSF & treatment with steroid reduces MMP9 concentrations Treatment with MMP inhibitor GM-6001 suppresses development of clinical experimental allergic encephalomyelitis in mice In rats with experimental allergic neuritis, a broad spectrum MMP inhibitor, BB-1101, which also inhibits TACE, reduces damage to nerves
  • 34. Metalloproteinases regulate myelinogenesis. A. MMP9/12 in maturation of oligodendrocytes precursor cells to oligodendrocytes & extension of their processes MMP9 and 12 are known to influence myelin formation during development, this is achieved through effect of these MMPs on bioavailability ofIGF1. IGFBP6,. B. Demyelination in adult mouse spinal cord, MMP9 regulates remyelination. mechanism is clearance of NG2 proteoglycans, which constitutes an inhibitory barrier for maturation of oligodendrocytes & their subsequent reformation of myelin.
  • 35. Matrix metalloproteinase in neuroinflammation & MS: Neuroscientist 2002; 8; 586
  • 37. MMP in vascular cognitive impairment MMPs are induced by hypoxic hypoperfusion in white matter During hypoxia, HIF1α increases, leading to expression of many genes implicated in injury & repair Furin contributes to activation of MMPs implicated in injury HIF1α stimulates expression of substances that mediate repair, including VEGF & TGFβ In rat model of VCI , hypoxic hypoperfusion induces MMPs & thus increases permeability of BBB in white matter
  • 38. Possible mechanism for white matter injury in vascular cognitive impairment HIF1α concentration, turns on cassettes of genes associated with injury such as FURIN, & increases expression of VEGF and TGFβ, which are important in repair. Furin leads to activation of MMP2 through activation of MT-MMP. MMP2 can disrupt tight junction proteins & open the BBB, leading to edema. Edema might also cause demyelination. Additionally, MMP2 might attack myelin and can activate endothelin 1, which causes vasoconstriction through calcium metabolism in small muscle. Vasoconstriction aggravates hypoxic state. Conversely, on the repair side, VEGF and TGFβ activate angiopoietin 2, which acts through the secretion of MMPs to initiate angiogenesis and neurogenesis.
  • 39. (E) Immunostaining with antibodies to MMP3 detects an immunoreactive astrocytes (arrow). (F) Immunostaining with antibodies to MMP3 detects an MMP3-positive macrophage around a fibrotic blood vessel in demyelinated area (arrow).
  • 40. MMPs & ADAMs in AD MMPs participate in formation & clearance of amyloid-β peptides (Aβ) MMPs are induced endogenously by amyloid molecules in blood vessels, astrocytes, & microglia Astrocytes exposed to Aβ1-40 secrete MMP2,3 & 9 When Aβ is deposited in tissues around plaques, there is activation of microglia & astrocytosis, this inflammatory response might contribute to neuronal Death Increase in expression of MMPs in brain tissue & blood of patients with AD is probably part of inflammatory response
  • 41. ADAMs are part of α- secretase α-secretase cleaves APP molecule, soluble fragment of APP is produced (APPsα), which can be further metabolized by proteases & cleared from brain across BBB. However, if β-secretase initiates cleavage of APP to form interim product that γ-secretase cleaves, then the Aβ molecule is formed. Most common form of Aβ is Aβ1-40, which is degraded by MMPs cleared through BBB : a smaller amount of Aβ1-42 is formed, but this can clump into fibrils that accumulate in amyloid plaques. MMP2 and MMP9 degrade Aβ & aid in its clearance from brain across BBB. Furthermore, microglia are activated by Aβ, adding to the amount of MMP9 available. Aβ=am
  • 42. MMPs in Parkinson’s disease In vitro, apoptotic dopaminergic neurons release MMP3, which activates microglia , suggesting that, MMP3 is signalling molecule in addition. TNFα released from microglia leads to neuronal death; Primary mouse mesencephalic cells in culture die when treated with BH4 (tetrahydrobiopterin), selective dopaminergic neuronal toxin; treatment with MMP3 inhibitor NNGH (N-isobutyl-N-[4-methoxyphenylsulfonyl]-glycylhydroxamic acid) prolongs cell survival by decreasing TNFα release from activated microglia.
  • 43. Determinants of beneficial or detrimental roles
  • 44. At least 3 factors contribute Stage of CNS injury – it is likely that in early phase after insult, when many metalloproteinases are induced or released into milieu that normally has low levels of protease MMPs are detrimental Indeed, in rodents, early & short-term treatment (for 3 days) of spinal cord injury or intracerebral hemorrhage with metalloproteinase inhibitors attenuates extent of neurotoxicity & subsequent loss of function More latterly after injury, when metalloproteinases are expressed discreetly and locally
  • 45. Type of injury inflicted Type of injury affects profile of inflammatory cells at injury site & available MMP substrates expressed in that microenvironment chronic diseases such as MS & EAE entail significant representation by T lymphocytes, which promote inflammation & neurotoxicity, whereas in acute spinal cord injury, injury site is infiltrated with neutrophils & macrophages rather than T cells In different cellular contexts, & with differences in gene expression in these cell types, substrates for,& functions of, MMP differ
  • 46. 3. Pathophysiology of disorder involved In EAE, recovery from disease depends on switch of CD4+ T lymphocytes from proinflammatory Th1 subset to Th2 environment in order for inflammation to subside MMP12 may be required for this switch,& its absence results in animals with more inflamed CNS & greater EAE severity By contrast, in cord injury, which represents insult less dependent on T cells, MMP12 may not be required to alter this ratio Rather, MMP12 expression increases activation of microglia/ macrophages, which exacerbate damage to injured cord
  • 47. Targeting MMP in Neurological conditions
  • 48.
  • 49.
  • 50. MMP inhibitors Early recognition that excessive MMP expression contributes to diseases such as cancer led to active development of inhibitors One of first hydroxamates developed was batimastat (BB94). Marimastat second generation hydroxamate with increased bioavailability after oral intake,& has been tested in gliomas Tetracycline antibiotics inhibits MMP enzymatic activity has led to use of these & chemically modified tetracyclines without anti-microbial activity (CMTs) as MMP inhibitors Only compound approved for use based on its ability to inhibit MMPs is low-dose doxycycline formulation, Periostat
  • 51. MMP in demyelinating & inflammatory disorders
  • 52. One of most potent tetracyclines to inhibit gelatinases, is minocycline. minocycline in EAE reduces disease activity Minocycline was found to reduce relapse rate & gad enhancing MRI lesions in pilot trial in RRMS CMT as MMP inhibitors acts by binding Zn2+ &Ca2+, latter being required to maintain proper enzyme conformation CMTs also down regulate expression of MMPs, & to decrease oxidative activation of pro-MMPs into active enzymes Statins, are also described to reduce production of MMPs by cells or to inhibit MMP activity
  • 53.
  • 54.
  • 56. Antibodies to MMPs & broad-spectrum MMP inhibitors, BB-94, 1101, & GM-6001, reduce BBB damage, infarct size, & cell death Protect brain from hemorrhagic complications of alteplase by reducing permeability of BBB & preventing alteplase from entering brain & activating MMPs MMP inhibitors in stroke needs to be given early in first few days after injury to prevent blocking recovery phase MRI has shown in rats that, although BB-1101 blocked early opening of BBB at 3hr after 90-min MCA occlusion with reperfusion, inhibitor had no effect on lesion size at 48 h, & recovery over 3 weeks was slowed
  • 57.
  • 58. MMP INHIBITORS IN OTHER DISEASES
  • 59. MMP inhibitors were beneficial in animal studies of MS,GBS , meningitis & vascular dementia MMPs in bacterial meningitis contribute to damage seen in children with meningitis despite use of appropriate antibiotics Water-soluble inhibitor of MMPs & TACE, TNF-484, is effective in animals Doxycycline blocks secondary damage in experimental bacterial meningitis in rodents Doxycycline has been used in treatment of MMP-mediated vascular diseases & reduced vascular damage in animal model
  • 60. Even more speculative is possible use of MMP inhibitors in treatment of Alzheimer’s disease Role of MMPs & ADAMs in AD is complex because of their dual function Theoretically, treatment with MMP inhibitors could impede amyloid clearance because MMP9 seems to facilitate removal of the amyloid peptides Use of MMP inhibitors in PD might show great promise as death of dopaminergic neurons seems to be associated with release of MMPs by the activated cells around them
  • 61.
  • 62. WHY WE ARE NOT USING MMPs?
  • 63. Major obstacle is low specificity & poor solubility particularly those with hydroxymate base Other obstacle is poor understanding of time to initiate & time to stop treatment Need to assess beneficial & deleterious effects in detail Selective inhibition VS broad spectrum inhibition Side effects
  • 64. CONCLUSIONS Metalloproteinases have both beneficial and detrimental functions in the CNS Issue of MMPs as causative factors in disease is active area of investigation, but their possible role as facilitators of CNS recovery needs greater consideration. Research needed to understand diverse roles of proteases to design specific drugs & devise therapeutic strategies The potential use of MMP inhibitors to treat CNS diseases is an exciting prospect, but it is important to balance risk with the benefits of this treatment